hims glp 1 safe & Hers swings to a loss in Q1 amid shift in GLP-1 strategy GLP-1 Drugs from the Gray

In the U.S., list prices for GLP-1-based medications are up to $1,000 or more a month before insurance

Compounded semaglutide or tirzepatide protocols at PlexusDx run $149/mo

The company's support team provides tracking updates when requested

One major research goal is to separate appetite suppression from nausea

ChapaDe Indian Health is launching a new virtual (Zoom) class called Weight Loss Connections , designed to support Chapa-De patients who are working on weight loss, especially those who can no longer access GLP1 medications

For currently approved GLP-1 receptor agonists available for weight management in the UK, NICE has established specific eligibility criteria: Semaglutide (Wegovy) NICE TA875 recommends semaglutide for adults with: A body mass index (BMI) of 35 kg/m or above with at least one weight-related comorbidity (such as hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease), or A BMI of 3034.9 kg/m with at least one weight-related comorbidity, prescribed only in specialist weight management services Evidence of previous unsuccessful weight loss attempts through diet, physical activity, and behavioural interventions Treatment is limited to a maximum of 2 years Liraglutide (Saxenda) NICE TA664 recommends liraglutide for adults with: A BMI of 35 kg/m or above (with or without comorbidities), or A BMI of 3034.9 kg/m with at least one weight-related comorbidity Evidence of previous unsuccessful weight loss attempts Treatment is limited to a maximum of 2 years Both medications must be prescribed as part of a specialist weight management service providing multidisciplinary support, including dietary advice, physical activity programmes, and behavioural interventions